Most Recent

image: Contributors

Contributors

By | April 1, 2016

Meet some of the people featured in the April 2016 issue of The Scientist.

0 Comments

image: Guts and Glory

Guts and Glory

By | April 1, 2016

An open mind and collaborative spirit have taken Hans Clevers on a journey from medicine to developmental biology, gastroenterology, cancer, and stem cells.

1 Comment

image: Parallel Plagues

Parallel Plagues

By | April 1, 2016

Like cancer, ecological scourges result from the breakdown of regulatory processes, and may be treated with similar logic.

0 Comments

A study suggests bats in Asia could have genes that protect them from the fungal infection that is decimating bat populations in North America.

0 Comments

image: Adjustable Brain Cells

Adjustable Brain Cells

By | February 18, 2016

Neighboring neurons can manipulate astrocytes. 

1 Comment

image: Capsule Reviews

Capsule Reviews

By | February 1, 2016

What Should a Clever Moose Eat?, The Illusion of God's Presence, GMO Sapiens, and Why We Snap

1 Comment

image: Keep Off the Grass

Keep Off the Grass

By | February 1, 2016

Ecologists focused on grasslands urge policymakers to keep forestation efforts in check.

0 Comments

image: Jason Holliday: Tree Tracker

Jason Holliday: Tree Tracker

By | February 1, 2016

Associate Professor, Virginia Tech, Department of Forest Resources and Environmental Conservation. Age: 37

0 Comments

image: PubPeer’s Appeal for Anonymity Continues

PubPeer’s Appeal for Anonymity Continues

By | January 21, 2016

The site’s lawyers, along with renowned scientists, filed briefs to an appeals court asking to protect a commenter’s identification.

3 Comments

image: “Heroes of CRISPR” Disputed

“Heroes of CRISPR” Disputed

By | January 19, 2016

Critics have harsh words for the Broad Institute’s Eric Lander and Cell over a recent perspective piece describing the history of CRISPR.

10 Comments

Popular Now

  1. Consilience, Episode 3: Cancer, Obscured
  2. RNAi’s Future in Drug-Target Screening
    News Analysis RNAi’s Future in Drug-Target Screening

    A recent CRISPR study contradicted years of RNA interference research on a well-studied cancer drug target. But is it the last nail in the coffin for RNAi as a screening tool? 

  3. A History of Screening for Natural Products to Fight Cancer
  4. Streakers, Poopers, and Performers: The Wilder Side of Wildlife Cameras
AAAS